Literature DB >> 23733307

Neurovirulence of Cryptococcus neoformans determined by time course of capsule accumulation and total volume of capsule in the brain.

A Pool1, L Lowder, Y Wu, K Forrester, J Rumbaugh.   

Abstract

Cryptococcal meningitis remains a significant opportunistic infection in HIV-infected individuals worldwide, despite availability of antiretroviral therapies in developed nations. Current therapy with amphotericin B is difficult to administer and only partially effective. Mechanisms of cryptococcal neuropathogenesis are still not clearly defined. In the present study, we used a C57Bl/6 mouse model with intravenous inoculation of three isogenic strains of Cryptococcus neoformans: H99, Cap59, and Pkr1-33. These strains differ in their capsule production and are normocapsular, hypocapsular, and hypercapsular, respectively. We studied the role of capsule in the morbidity and mortality of our host animal. Surprisingly, we found that the hypercapsular strain was least virulent while the strains that produced less capsule were more virulent and had higher concentrations of organism in the brain. These results suggest that neurovirulence is related to total capsule volume and rate of capsule accumulation in the brain, rather than the amount of capsule produced per organism. Therapies which decrease central nervous system dissemination and inhibit replication rates in the brain may be more effective than therapies which target capsule production.

Entities:  

Mesh:

Year:  2013        PMID: 23733307     DOI: 10.1007/s13365-013-0169-7

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  57 in total

1.  Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection.

Authors:  Kirsten Nielsen; Gary M Cox; Anastasia P Litvintseva; Eleftherios Mylonakis; Stephanie D Malliaris; Daniel K Benjamin; Steven S Giles; Thomas G Mitchell; Arturo Casadevall; John R Perfect; Joseph Heitman
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice.

Authors:  K A Hoag; M F Lipscomb; A A Izzo; N E Street
Journal:  Am J Respir Cell Mol Biol       Date:  1997-12       Impact factor: 6.914

3.  Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity.

Authors:  S J Devi; R Schneerson; W Egan; T J Ulrich; D Bryla; J B Robbins; J E Bennett
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

4.  High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.

Authors:  Tihana Bicanic; Robin Wood; Graeme Meintjes; Kevin Rebe; Annemarie Brouwer; Angela Loyse; Linda-Gail Bekker; Shabbar Jaffar; Thomas Harrison
Journal:  Clin Infect Dis       Date:  2008-07-01       Impact factor: 9.079

5.  Cryptococcus neoformans capsule structure evolution in vitro and during murine infection.

Authors:  Dea Garcia-Hermoso; Françoise Dromer; Guilhem Janbon
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

6.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

7.  Splenic and lung response to nonlethal systemic Aspergillus fumigatus infection in C57BL/6 mice.

Authors:  Ivana Mirkov; Ivana Stojanovic; Stanislava Stosic-Grujicic; Jasmina Glamoclija; Lidija Zolotarevski; Dragan Kataranovski; Milena Kataranovski
Journal:  Med Mycol       Date:  2010-08       Impact factor: 4.076

8.  A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients.

Authors:  Edmond J Byrnes; Wenjun Li; Ping Ren; Yonathan Lewit; Kerstin Voelz; James A Fraser; Fred S Dietrich; Robin C May; Sudha Chaturvedi; Sudha Chatuverdi; Vishnu Chaturvedi; Vishnu Chatuverdi; Joseph Heitman
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

9.  Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans.

Authors:  Won Hee Jung; Anita Sham; Rick White; James W Kronstad
Journal:  PLoS Biol       Date:  2006-11       Impact factor: 8.029

10.  Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.

Authors:  Françoise Dromer; Simone Mathoulin-Pélissier; Odile Launay; Olivier Lortholary
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

View more
  9 in total

1.  Lineages Derived from Cryptococcus neoformans Type Strain H99 Support a Link between the Capacity to Be Pleomorphic and Virulence.

Authors:  Kenya E Fernandes; James A Fraser; Dee A Carter
Journal:  mBio       Date:  2022-03-08       Impact factor: 7.786

2.  Species in the Cryptococcus gattii Complex Differ in Capsule and Cell Size following Growth under Capsule-Inducing Conditions.

Authors:  Kenya E Fernandes; Christine Dwyer; Leona T Campbell; Dee A Carter
Journal:  mSphere       Date:  2016-12-28       Impact factor: 4.389

3.  CD4+ T Cells Orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis.

Authors:  Lori M Neal; Enze Xing; Jintao Xu; Jessica L Kolbe; John J Osterholzer; Benjamin M Segal; Peter R Williamson; Michal A Olszewski
Journal:  MBio       Date:  2017-11-21       Impact factor: 7.867

Review 4.  The capsule of Cryptococcus neoformans.

Authors:  Arturo Casadevall; Carolina Coelho; Radames J B Cordero; Quigly Dragotakes; Eric Jung; Raghav Vij; Maggie P Wear
Journal:  Virulence       Date:  2018-08-01       Impact factor: 5.882

Review 5.  Influence of Pathogen Carbon Metabolism on Interactions With Host Immunity.

Authors:  Hannah P Berguson; Lauren W Caulfield; Michael S Price
Journal:  Front Cell Infect Microbiol       Date:  2022-03-17       Impact factor: 5.293

Review 6.  The Consequences of Our Changing Environment on Life Threatening and Debilitating Fungal Diseases in Humans.

Authors:  Norman van Rhijn; Michael Bromley
Journal:  J Fungi (Basel)       Date:  2021-05-07

7.  Phenotypic Variability Correlates with Clinical Outcome in Cryptococcus Isolates Obtained from Botswanan HIV/AIDS Patients.

Authors:  Kenya E Fernandes; Adam Brockway; Miriam Haverkamp; Christina A Cuomo; Floris van Ogtrop; John R Perfect; Dee A Carter
Journal:  mBio       Date:  2018-10-23       Impact factor: 7.867

8.  A Wor1-Like Transcription Factor Is Essential for Virulence of Cryptococcus neoformans.

Authors:  Hugo Costa Paes; Lorena da Silveira Derengowski; Luisa Defranco Ferreira Peconick; Patrícia Albuquerque; Georgios Joannis Pappas; André Moraes Nicola; Fabiana Brandão Alves Silva; Marcelo Afonso Vallim; J Andrew Alspaugh; Maria Sueli Soares Felipe; Larissa Fernandes
Journal:  Front Cell Infect Microbiol       Date:  2018-11-13       Impact factor: 5.293

9.  Lactoferrin Is Broadly Active against Yeasts and Highly Synergistic with Amphotericin B.

Authors:  Kenya E Fernandes; Kerry Weeks; Dee A Carter
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.